Latest News on Dcgi
Showing of 0 - 10 from 12 results
Dcgi - Total results - 12
-
Apr 03, 2019
Presence of animal gelatin in capsules, food ails consumer; vegan alternative need of the hour
There are vegan alternatives to gelatine: agar agar, pectin, starches, gums. But companies using gelatin say that they do not have the same chemical and mechanical properties. They are also slightly more expensive. -
Dec 20, 2018
DCGI orders Johnson & Johnson not to use talc raw material for any production till further orders
On the directions of the CDSCO, drug inspectors collected samples of Johnson & Johnson's baby powder from both the plants on Wednesday. -
Jan 07, 2018
Eight Chinese pharma cos to be blacklisted for quality issues, may lead to shortage of medicines
The Indian government has issued show cause notices to, and may soon blacklist, eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers in this country -
Apr 25, 2017
Cost of cardiac stents cut by 75%: Dept of pharmaceuticals prohibits manufacturers from withdrawing products
After the National Pharmaceutical Pricing Authority (NPPA), India's drug pricing regulator, reduced the price of cardiac stents by almost 75 percent, the government now has prohibited stent-makers from withdrawing their products from the market for the next six months. -
Jun 23, 2016
Biocon and partner Quark get DCGI approval for trials of new eye disease drug
Biocon and Quark Pharmaceuticals also announced the randomisation of the first patient in India in the global Phase II/III study of the new drug candidate -
Mar 16, 2016
P&G stops sale of 'Vicks Action 500 Extra', vows to challenge ban
Array -
May 21, 2014
Govt to spend Rs 3,000 cr to set up labs, double drug regulators
When asked about some concerns, Pandey said, "Government stands behind zero tolerance when it comes to human lives. Indian laws are the toughest." -
May 02, 2014
Nearly 30,000 packs of allergy-relief drug recalled by Ranbaxy in US
All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches -
Mar 18, 2014
US doctors worried about drugs manufactured by Indian pharma
India supplies about 40 percent of generic and over-the-counter drugs used in the United States, making it the second-biggest supplier after Canada. -
Mar 14, 2014
Drugs sold in Indian markets safe, Ranbaxy tells SC
The Supreme Court today issued notice to Centre and Ranbaxy Laboratories on a PIL seeking cancellation of the company's licence and a CBI probe against it for allegedly supplying adulterated drugs in the country.
